Zepbound is off to a good start, but here's what Eli Lilly investors are watching
Hopes are sky-high for Eli Lilly's recently launched weight-loss drug Zepbound. Investors will tune into the company's fourth-quarter earnings conference…
health care industry
Tyson Foods Leaves CVS, Picks Rightway Pharmacy Benefit Manager
Tyson Foods Inc., sign at Tyson headquarters in Springdale, Arkansas. April L. Brown | AP Tyson Foods will become one…
Johnson & Johnson to resolve baby powder investigation
Containers of Johnson and Johnson baby powder are displayed on a shelf at Walgreens on April 5, 2023 in San…
Johnson & Johnson (JNJ) Q4 2023 Earnings
Johnson & Johnson stock chart seen on a smartphone screen. Rafael Enrique | SOPA Images | Light rocket | fake…
These four stocks of anti-obesity drugs could skyrocket, says Berenberg
The anti-obesity drug market is expected to remain in the spotlight this year after a bumper 2023 for weight loss…
Gilead Shares Fall After Disappointing Lung Cancer Study Results
soup images | Light rocket | fake images Actions of Gilead fell more than 9% on Monday after a key…
Boehringer Ingelheim, Terns and Viking could join the market
Still life of Wegovy, an injectable prescription weight loss medication that has helped people with obesity. It should be used…
Citi and others are bullish on biotech, medtech and more
2023 was not a good year for the healthcare sector, but some investors expect it to return this year, highlighting…
Defense Secretary Austin is 'actively engaged and engaged' while hospitalized
United States Secretary of Defense Lloyd J. Austin testifies before a House Armed Services Committee hearing on the conclusion of…
Renewed interest in ADCs will continue in 2024
Medical personnel use a mammogram to examine a woman's breast for breast cancer. Hannibal Hanschke | dpa | Image Alliance…